Form 4: Boston Scientific Director Ellen M. Zane Receives Equity Award

Director Ellen M. Zane acquired 2,081 shares of Boston Scientific common stock through an annual equity award.

Summary

• On May 8, 2025, Ellen M. Zane, a director of Boston Scientific Corp, acquired 2,081 shares of common stock.
• The acquisition was an annual equity award.
• The shares were acquired at a price of $0.00.
• Following the transaction, Ms. Zane directly owns 37,025 shares of Boston Scientific common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine equity award to a director, which is generally viewed as a positive sign of aligning management interests with shareholders. There are no indications of negative news or concerns.

Positives

• The equity award aligns the director's interests with those of the shareholders.
• The vesting schedule encourages continued service and commitment to the company.

Future Outlook

The restricted stock will vest upon the next annual meeting of stockholders.

Industry Context

Equity awards to directors are a common practice in publicly traded companies to incentivize and align their interests with those of shareholders. The size and structure of the award are typical for directors of companies of Boston Scientific's size and complexity.

Comparison to Industry Standards

• Director compensation packages, including equity awards, vary across the medical device industry.
• Companies like Medtronic and Abbott also provide equity-based compensation to their directors, with the specific amounts and vesting schedules dependent on factors such as company performance and individual contributions.
• The $215,000 valuation of the equity award appears to be within the typical range for directors at similarly sized medical device companies.

Stakeholder Impact

• The equity award aligns the director's interests with those of the shareholders, potentially leading to better decision-making for the company.
• Employees may view the equity award as a positive sign of the company's commitment to its leadership.

Next Steps

• The restricted stock will vest upon the next annual meeting of stockholders.

Key Dates

Keywords

equity award, director, common stock, Boston Scientific, BSX, Form 4, Zane, insider transaction